Read + Share
Pan J, Ping PD, Wang W, Zhou JM, et al. Cost-effectiveness analysis of Shexiang Baoxin Pill (MUSKARDIA) as the add-on
treatment to standard therapy for stable coronary artery disease in China. PLoS One 2024;19:e0299236.
PMID: 38427636
|
 |
|
Pan J, Ping PD, Wang W, Zhou JM, et al. Cost-effectiveness analysis of Shexiang Baoxin Pill (MUSKARDIA) as the add-on
treatment to standard therapy for stable coronary artery disease in China. PLoS One 2024;19:e0299236.
PMID: 38427636
|
|
|
|